{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:43:45Z","timestamp":1793720625840,"version":"4.6.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T00:00:00Z","timestamp":1549670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571603"],"award-info":[{"award-number":["81571603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701615"],"award-info":[{"award-number":["81701615"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006739","name":"Capital Foundation of Medical Development","doi-asserted-by":"publisher","award":["2016-2-4063"],"award-info":[{"award-number":["2016-2-4063"]}],"id":[{"id":"10.13039\/501100006739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"crossref","award":["Z181100001718063"],"award-info":[{"award-number":["Z181100001718063"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10067-019-04457-w","type":"journal-article","created":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T06:28:13Z","timestamp":1549693693000},"page":"1655-1663","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody"],"prefix":"10.1007","volume":"38","author":[{"given":"Lili","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,9]]},"reference":[{"issue":"12","key":"4457_CR1","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1007\/s00296-011-2323-y","volume":"32","author":"F Chen","year":"2012","unstructured":"Chen F, Wang D, Shu X, Nakashima R, Wang G (2012) Anti-MDA5 antibody is associated with a\/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis. Rheumatol Int 32(12):3909\u20133915. https:\/\/doi.org\/10.1007\/s00296-011-2323-y","journal-title":"Rheumatol Int"},{"issue":"3","key":"4457_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","volume":"23","author":"S Sato","year":"2013","unstructured":"Sato S, Kuwana M, Fujita T, Suzuki Y (2013) Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol 23(3):496\u2013502. https:\/\/doi.org\/10.1007\/s10165-012-0663-4","journal-title":"Mod Rheumatol"},{"issue":"7","key":"4457_CR3","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/rheumatology\/ker518","volume":"51","author":"T Koga","year":"2012","unstructured":"Koga T, Fujikawa K, Horai Y, Okada A, Kawashiri SY, Iwamoto N, Suzuki T, Nakashima Y, Tamai M, Arima K, Yamasaki S, Nakamura H, Origuchi T, Hamaguchi Y, Fujimoto M, Ishimatsu Y, Mukae H, Kuwana M, Kohno S, Eguchi K, Aoyagi K, Kawakami A (2012) The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology (Oxford, England) 51(7):1278\u20131284. https:\/\/doi.org\/10.1093\/rheumatology\/ker518","journal-title":"Rheumatology (Oxford, England)"},{"issue":"34","key":"4457_CR4","doi-asserted-by":"crossref","first-page":"25803","DOI":"10.1016\/S0021-9258(19)74461-5","volume":"268","author":"BE Hakala","year":"1993","unstructured":"Hakala BE, White C, Recklies AD (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268(34):25803\u201325810","journal-title":"J Biol Chem"},{"key":"4457_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-physiol-012110-142250","volume":"73","author":"CG Lee","year":"2011","unstructured":"Lee CG, Da Silva CA, Dela Cruz CS, Ahangari F, Ma B, Kang MJ, He CH, Takyar S, Elias JA (2011) Role of chitin and chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol 73:479\u2013501. https:\/\/doi.org\/10.1146\/annurev-physiol-012110-142250","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"4457_CR6","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1006\/bbrc.2001.5253","volume":"285","author":"F Ceuninck De","year":"2001","unstructured":"De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P (2001) YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun 285(4):926\u2013931. https:\/\/doi.org\/10.1006\/bbrc.2001.5253","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"4457_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14017430802220567","volume":"42","author":"Y Wang","year":"2008","unstructured":"Wang Y, Ripa RS, Johansen JS, Gabrielsen A, Steinbruchel DA, Friis T, Bindslev L, Haack-Sorensen M, Jorgensen E, Kastrup J (2008) YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease. Scand Cardiovasc J 42(5):295\u2013302. https:\/\/doi.org\/10.1080\/14017430802220567","journal-title":"Scand Cardiovasc J"},{"key":"4457_CR8","doi-asserted-by":"publisher","unstructured":"Papadopoulou-Marketou N, Chrousos GP, Kanaka-Gantenbein C (2017) Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis. Diabetes Metab Res Rev 33(2). https:\/\/doi.org\/10.1002\/dmrr.2841","DOI":"10.1002\/dmrr.2841"},{"key":"4457_CR9","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1186\/s12885-015-1592-3","volume":"15","author":"M Jefri","year":"2015","unstructured":"Jefri M, Huang YN, Huang WC, Tai CS, Chen WL (2015) YKL-40 regulated epithelial-mesenchymal transition and migration\/invasion enhancement in non-small cell lung cancer. BMC Cancer 15:590. https:\/\/doi.org\/10.1186\/s12885-015-1592-3","journal-title":"BMC Cancer"},{"issue":"8","key":"4457_CR10","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.rmed.2010.02.026","volume":"104","author":"K Furuhashi","year":"2010","unstructured":"Furuhashi K, Suda T, Nakamura Y, Inui N, Hashimoto D, Miwa S, Hayakawa H, Kusagaya H, Nakano Y, Nakamura H, Chida K (2010) Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis. Respir Med 104(8):1204\u20131210. https:\/\/doi.org\/10.1016\/j.rmed.2010.02.026","journal-title":"Respir Med"},{"issue":"9","key":"4457_CR11","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3899\/jrheum.170373","volume":"44","author":"H Hozumi","year":"2017","unstructured":"Hozumi H, Fujisawa T, Enomoto N, Nakashima R, Enomoto Y, Suzuki Y, Kono M, Karayama M, Furuhashi K, Murakami A, Inui N, Nakamura Y, Mimori T, Suda T (2017) Clinical utility of YKL-40 in polymyositis\/dermatomyositis-associated interstitial lung disease. J Rheumatol 44(9):1394\u20131401. https:\/\/doi.org\/10.3899\/jrheum.170373","journal-title":"J Rheumatol"},{"issue":"7","key":"4457_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344\u2013347. https:\/\/doi.org\/10.1056\/nejm197502132920706","journal-title":"N Engl J Med"},{"issue":"8","key":"4457_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403\u2013407. https:\/\/doi.org\/10.1056\/nejm197502202920807","journal-title":"N Engl J Med"},{"issue":"3","key":"4457_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0733-8635(02)00021-9","volume":"20","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD (2002) Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 20(3):387\u2013408. https:\/\/doi.org\/10.1016\/S0733-8635(02)00021-9","journal-title":"Dermatol Clin"},{"issue":"7","key":"4457_CR15","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","volume":"176","author":"HR Collard","year":"2007","unstructured":"Collard HR, Collard HR, Moore BB et al (2007) Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176(7):636\u2013643. https:\/\/doi.org\/10.1164\/rccm.200703-463PP","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"4457_CR16","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, M\u00fcller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Sch\u00fcnemann HJ (2011) An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183(6):788\u2013824. https:\/\/doi.org\/10.1164\/rccm.2009-040GL","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"4457_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837\u2013845","journal-title":"Biometrics"},{"issue":"20","key":"4457_CR18","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1056\/NEJMoa073600","volume":"357","author":"GL Chupp","year":"2007","unstructured":"Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, He S, Dziura JD, Reed J, Coyle AJ, Kiener P, Cullen M, Grandsaigne M, Dombret MC, Aubier M, Pretolani M, Elias JA (2007) A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 357(20):2016\u20132027. https:\/\/doi.org\/10.1056\/NEJMoa073600","journal-title":"N Engl J Med"},{"issue":"4","key":"4457_CR19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1165\/rcmb.2006-0121OC","volume":"35","author":"AL Mora","year":"2006","unstructured":"Mora AL, Torres-Gonzalez E, Rojas M, Corredor C, Ritzenthaler J, Xu J, Roman J, Brigham K, Stecenko A (2006) Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. Am J Respir Cell Mol Biol 35(4):466\u2013473. https:\/\/doi.org\/10.1165\/rcmb.2006-0121OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"27","key":"4457_CR20","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.2174\/138161212802430396","volume":"18","author":"AN Lekkerkerker","year":"2012","unstructured":"Lekkerkerker AN, Aarbiou J, van Es T, Janssen RA (2012) Cellular players in lung fibrosis. Curr Pharm Des 18(27):4093\u20134102","journal-title":"Curr Pharm Des"},{"key":"4457_CR21","doi-asserted-by":"publisher","unstructured":"Mathai SK, Gulati M, Peng X, Russell TR, Shaw AC, Rubinowitz AN, Murray LA, Siner JM, Antin-Ozerkis DE, Montgomery RR, Reilkoff RA, Bucala RJ, Herzog EL (2010) Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.\u00a0Lab Invest 90(6):812\u2013823. https:\/\/doi.org\/10.1038\/labinvest.2010.73","DOI":"10.1038\/labinvest.2010.73"},{"issue":"3","key":"4457_CR22","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/art.38288","volume":"66","author":"RB Christmann","year":"2014","unstructured":"Christmann RB, Sampaio-Barros P, Stifano G, Borges CL, de Carvalho CR, Kairalla R, Parra ER, Spira A, Simms R, Capellozzi VL, Lafyatis R (2014) Association of interferon- and transforming growth factor beta-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis. Arthritis Rheum 66(3):714\u2013725. https:\/\/doi.org\/10.1002\/art.38288","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4457_CR23","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3899\/jrheum.141307","volume":"42","author":"QL Peng","year":"2015","unstructured":"Peng QL, Zhang YL, Shu XM, Yang HB, Zhang L, Chen F, Lu X, Wang GC (2015) Elevated serum levels of soluble CD163 in polymyositis and dermatomyositis: associated with macrophage infiltration in muscle tissue. J Rheumatol 42(6):979\u2013987. https:\/\/doi.org\/10.3899\/jrheum.141307","journal-title":"J Rheumatol"},{"issue":"1","key":"4457_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13075-016-1214-8","volume":"19","author":"Y Enomoto","year":"2017","unstructured":"Enomoto Y, Suzuki Y, Hozumi H, Mori K, Kono M, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suzuki D, Ogawa N, Nakashima R, Mimori T, Iwashita T, Suda T (2017) Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease. Arthritis Res Ther 19(1):9. https:\/\/doi.org\/10.1186\/s13075-016-1214-8","journal-title":"Arthritis Res Ther"},{"issue":"16","key":"4457_CR25","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2169\/internalmedicine.55.5774","volume":"55","author":"H Chino","year":"2016","unstructured":"Chino H, Sekine A, Baba T, Iwasawa T, Okudela K, Takemura T, Itoh H, Sato S, Suzuki Y, Ogura T (2016) Radiological and pathological correlation in anti-MDA5 antibody-positive interstitial lung disease: rapidly progressive perilobular opacities and diffuse alveolar damage. Intern Med (Tokyo, Japan) 55(16):2241\u20132246. https:\/\/doi.org\/10.2169\/internalmedicine.55.5774","journal-title":"Intern Med (Tokyo, Japan)"},{"issue":"5","key":"4457_CR26","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, Nishikawa T, Oddis CV, Ikeda Y (2005) Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 52(5):1571\u20131576. https:\/\/doi.org\/10.1002\/art.21023","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4457_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bjd.14882","volume":"176","author":"T Matsushita","year":"2017","unstructured":"Matsushita T, Mizumaki K, Kano M, Yagi N, Tennichi M, Takeuchi A, Okamoto Y, Hamaguchi Y, Murakami A, Hasegawa M, Kuwana M, Fujimoto M, Takehara K (2017) Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis. Br J Dermatol 176(2):395\u2013402. https:\/\/doi.org\/10.1111\/bjd.14882","journal-title":"Br J Dermatol"},{"issue":"1","key":"4457_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/14397595.2017.1318468","volume":"28","author":"Y Fujiki","year":"2018","unstructured":"Fujiki Y, Kotani T, Isoda K, Ishida T, Shoda T, Yoshida S, Takeuchi T, Makino S (2018) Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients. Mod Rheumatol 28(1):133\u2013140. https:\/\/doi.org\/10.1080\/14397595.2017.1318468","journal-title":"Mod Rheumatol"},{"issue":"9","key":"4457_CR29","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","volume":"51","author":"T Gono","year":"2012","unstructured":"Gono T, Sato S, Kawaguchi Y, Kuwana M, Hanaoka M, Katsumata Y, Takagi K, Baba S, Okamoto Y, Ota Y, Yamanaka H (2012) Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology (Oxford, England) 51(9):1563\u20131570. https:\/\/doi.org\/10.1093\/rheumatology\/kes102","journal-title":"Rheumatology (Oxford, England)"},{"issue":"8","key":"4457_CR30","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00296-017-3729-y","volume":"37","author":"K Isoda","year":"2017","unstructured":"Isoda K, Kotani T, Takeuchi T, Kiboshi T, Hata K, Ishida T, Otani K, Kamimori T, Fujiwara H, Shoda T, Makino S (2017) Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA synthetase antibodies versus anti-melanoma differentiation-associated gene 5 antibody. Rheumatol Int 37(8):1335\u20131340. https:\/\/doi.org\/10.1007\/s00296-017-3729-y","journal-title":"Rheumatol Int"},{"issue":"1","key":"4457_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10067-015-3139-z","volume":"35","author":"Y Xu","year":"2016","unstructured":"Xu Y, Yang CS, Li YJ, Liu XD, Wang JN, Zhao Q, Xiao WG, Yang PT (2016) Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis. Clin Rheumatol 35(1):113\u2013116. https:\/\/doi.org\/10.1007\/s10067-015-3139-z","journal-title":"Clin Rheumatol"},{"key":"4457_CR32","doi-asserted-by":"publisher","unstructured":"Nara M, Komatsuda A, Omokawa A, Togashi M, Okuyama S, Sawada K, Wakui H (2014) Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease. Mod Rheumatol 24 (4):633\u2013636. doi: https:\/\/doi.org\/10.3109\/14397595.2013.844390","DOI":"10.3109\/14397595.2013.844390"},{"key":"4457_CR33","doi-asserted-by":"publisher","first-page":"815245","DOI":"10.1155\/2014\/815245","volume":"2014","author":"H Kawasumi","year":"2014","unstructured":"Kawasumi H, Gono T, Kawaguchi Y, Kaneko H, Katsumata Y, Hanaoka M, Kataoka S, Yamanaka H (2014) IL-6, IL-8, and IL-10 are associated with hyperferritinemia in rapidly progressive interstitial lung disease with polymyositis\/dermatomyositis. Biomed Res Int 2014:815245\u2013815246. https:\/\/doi.org\/10.1155\/2014\/815245","journal-title":"Biomed Res Int"},{"issue":"5","key":"4457_CR34","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/rheumatology\/keu385","volume":"54","author":"N Kobayashi","year":"2015","unstructured":"Kobayashi N, Takezaki S, Kobayashi I, Iwata N, Mori M, Nagai K, Nakano N, Miyoshi M, Kinjo N, Murata T, Masunaga K, Umebayashi H, Imagawa T, Agematsu K, Sato S, Kuwana M, Yamada M, Takei S, Yokota S, Koike K, Ariga T (2015) Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis. Rheumatology (Oxford, England) 54(5):784\u2013791. https:\/\/doi.org\/10.1093\/rheumatology\/keu385","journal-title":"Rheumatology (Oxford, England)"},{"issue":"2","key":"4457_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/s10165-010-0371-x","volume":"21","author":"T Gono","year":"2011","unstructured":"Gono T, Kawaguchi Y, Ozeki E, Ota Y, Satoh T, Kuwana M, Hara M, Yamanaka H (2011) Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis. Mod Rheumatol 21(2):223\u2013227. https:\/\/doi.org\/10.1007\/s10165-010-0371-x","journal-title":"Mod Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04457-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04457-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04457-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T17:13:08Z","timestamp":1662916388000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04457-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,9]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["4457"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04457-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,9]]},"assertion":[{"value":"21 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that manuscript has been read and approved by all authors. We have obtained the approval from the Research Review Committee (RRC) and the Ethical Review Committee (ERC) of the China-Japan Friendship Hospital. All the samples were obtained after the patients had provided written informed consent. This study was approved by the Research Review Committee and the Ethical Review Committee of the China-Japan Friendship Hospital (approval number 2016\u2013117).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}